Jpmorgan Chase & CO Sana Biotechnology, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 805,164 shares of SANA stock, worth $3.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
805,164
Previous 806,635 0.18%
Holding current value
$3.58 Million
Previous $1.31 Million 2.89%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$1.65 - $4.3 $2,427 - $6,325
-1,471 Reduced 0.18%
805,164 $1.35 Million
Q4 2024

Feb 12, 2025
SELL
$1.6 - $4.36 $176,860 - $481,945
-110,538 Reduced 12.05%
806,635 $1.31 Million
Q3 2024

Dec 26, 2024
SELL
$3.76 - $6.86 $129,310 - $235,922
-34,391 Reduced 3.61%
917,173 $3.82 Million
Q3 2024

Nov 08, 2024
SELL
$3.76 - $6.86 $129,310 - $235,922
-34,391 Reduced 3.61%
917,173 $3.82 Million
Q2 2024

Dec 26, 2024
BUY
$5.23 - $10.44 $179,864 - $359,042
34,391 Added 3.75%
951,564 $5.2 Million
Q2 2024

Aug 12, 2024
SELL
$5.23 - $10.44 $805,017 - $1.61 Million
-153,923 Reduced 13.92%
951,564 $5.2 Million
Q1 2024

Dec 26, 2024
BUY
$4.2 - $11.27 $790,918 - $2.12 Million
188,314 Added 20.53%
1,105,487 $11.1 Million
Q1 2024

May 10, 2024
SELL
$4.2 - $11.27 $357,617 - $959,606
-85,147 Reduced 7.15%
1,105,487 $11.1 Million
Q4 2023

Dec 26, 2024
BUY
$2.8 - $4.55 $765,690 - $1.24 Million
273,461 Added 29.82%
1,190,634 $4.86 Million
Q4 2023

Feb 12, 2024
BUY
$2.8 - $4.55 $37,245 - $60,524
13,302 Added 1.13%
1,190,634 $4.86 Million
Q3 2023

Nov 14, 2023
SELL
$3.77 - $6.23 $227,956 - $376,703
-60,466 Reduced 4.88%
1,177,332 $4.56 Million
Q2 2023

Aug 11, 2023
SELL
$3.22 - $7.53 $3.88 Million - $9.07 Million
-1,204,505 Reduced 49.32%
1,237,798 $7.38 Million
Q1 2023

May 18, 2023
BUY
$3.11 - $4.92 $344,855 - $545,559
110,886 Added 4.76%
2,442,303 $7.99 Million
Q1 2023

May 11, 2023
SELL
$3.11 - $4.92 $138,659 - $219,358
-44,585 Reduced 1.88%
2,331,417 $7.62 Million
Q4 2022

Feb 13, 2023
SELL
$3.19 - $6.46 $11,834 - $23,966
-3,710 Reduced 0.16%
2,376,002 $9.39 Million
Q3 2022

Nov 14, 2022
SELL
$5.58 - $9.04 $645,059 - $1.05 Million
-115,602 Reduced 4.63%
2,379,712 $14.3 Million
Q2 2022

Aug 11, 2022
BUY
$4.12 - $9.35 $39,284 - $89,152
9,535 Added 0.38%
2,495,314 $16 Million
Q1 2022

May 11, 2022
BUY
$5.24 - $15.58 $2.46 Million - $7.32 Million
469,673 Added 23.3%
2,485,779 $20.5 Million
Q4 2021

Feb 10, 2022
BUY
$15.18 - $23.15 $5.93 Million - $9.04 Million
390,684 Added 24.04%
2,016,106 $31.2 Million
Q3 2021

Nov 12, 2021
BUY
$16.29 - $25.88 $26.5 Million - $42.1 Million
1,625,422 New
1,625,422 $36.6 Million

Others Institutions Holding SANA

# of Institutions
166
Shares Held
112M
Call Options Held
414K
Put Options Held
295K
View Full List

About Sana Biotechnology, Inc.

SANA Quotes by TradingView
  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $847M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email